SEARCH

SEARCH BY CITATION

References

  • 1
    Bulun SE: Endometriosis. N Engl J Med 2009; 360:268279.
  • 2
    Bergqvist A: Different types of extragenital endometriosis: a review. Gynecol Endocrinol 1993; 7:207221.
  • 3
    Simoens S, Hummelshoj L, D’Hooghe T: Endometriosis: cost estimates and methodological perspective. Hum Reprod Update 2007; 13:395404.
  • 4
    Giudice LC: Clinical practice. Endometriosis. N Engl J Med 2010; 362:23892398.
  • 5
    Sampson JA: Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 1927; 3:93110.
  • 6
    Ho HN, Wu MY, Yang YS: Peritoneal cellular immunity and endometriosis. Am J Reprod Immunol 1997; 38:400412.
  • 7
    Kyama CM, Debrock S, Mwenda JM, D’Hooghe TM: Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol 2003; 1:123.
  • 8
    Christodoulakos G, Augoulea A, Lambrinoudaki I, Sioulas V, Creatsas G: Pathogenesis of endometriosis: the role of defective ‘immunosurveillance’. Eur J Contracept Reprod Health Care 2007; 12:194202.
  • 9
    Osuga Y, Koga K, Hirota Y, Hirata T, Yoshino O, Taketani Y: Lymphocytes in endometriosis. Am J Reprod Immunol 2011; 65:110.
  • 10
    Berbic M, Fraser IS: Regulatory T cells and other leukocytes in the pathogenesis of endometriosis. J Reprod Immunol 2011; 88:149155.
  • 11
    Sikora J, Mielczarek-Palacz A, Kondera-Anasz Z: Role of natural killer cell activity in the pathogenesis of endometriosis. Curr Med Chem 2011; 18:200208.
  • 12
    González-Ramos R, Van Langendonckt A, Defrère S, Lousse JC, Colette S, Devoto L, Donnez J: Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis. Fertil Steril 2010; 94:19851994.
  • 13
    Cakmak H, Guzeloglu-Kayisli O, Kayisli UA, Arici A: Immune-endocrine interactions in endometriosis. Front Biosci (Elite Ed) 2009; 1:429443.
  • 14
    Barbieri RL, Niloff JM, Bast Jr RC, Scaetzl E, Kistner RW, Knapp RC: Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril 1986; 45:630634.
  • 15
    Abrão MS, Podgaec S, Filho BM, Ramos LO, Pinotti JA, de Oliveira RM: The use of biochemical markers in the diagnosis of pelvic endometriosis. Hum Reprod 1997; 12:25232527.
  • 16
    Koninckx PR, Kennedy SH, Barlow DH: Endometriotic disease: the role of peritoneal fluid. Hum Reprod Update 1998; 4:741751.
  • 17
    Montgomery GW, Nyholt DR, Zhao ZZ, Treloar SA, Painter JN, Missmer SA, Kennedy SH, Zondervan KT: The search for genes contributing to endometriosis risk. Hum Reprod Update 2008; 14:447457.
  • 18
    Dun EC, Taylor RN, Wieser F: Advances in the genetics of endometriosis. Genome Med 2010; 2:75.
  • 19
    Painter JN, Anderson CA, Nyholt DR, Macgregor S, Lin J, Lee SH, Lambert A, Zhao ZZ, Roseman F, Guo Q, Gordon SD, Wallace L, Henders AK, Visscher PM, Kraft P, Martin NG, Morris AP, Treloar SA, Kennedy SH, Missmer SA, Montgomery GW, Zondervan KT: Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet 2011; 43:5154.
  • 20
    Kajihara H, Yamada Y, Kanayama S, Furukawa N, Noguchi T, Haruta S, Yoshida S, Sado T, Oi H, Kobayashi H: New insights into the pathophysiology of endometriosis: from chronic inflammation to danger signal. Gynecol Endocrinol 2011; 27:7379.
  • 21
    Latha M, Vaidya S, Movva S, Chava S, Govindan S, Govatati S, Banoori M, Hasan Q, Kodati VL: Molecular pathogenesis of endometriosis; Toll-like receptor-4 A896G (D299G) polymorphism: a novel explanation. Genet Test Mol Biomarkers 2011; 15:181184.
  • 22
    Barrier BF: Immunology of endometriosis. Clin Obstet Gynecol 2010; 53:397402.
  • 23
    Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P: High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 2002; 17:27152724.
  • 24
    Nielsen NM, Jørgensen KT, Pedersen BV, Rostgaard K, Frisch M: The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjogren syndrome. Hum Reprod 2011; 26: 15551559.
  • 25
    Petta CA, Arruda MS, Zantut-Wittmann DE, Benetti-Pinto CL: Thyroid autoimmunity and thyroid dysfunction in women with endometriosis. Hum Reprod 2007; 22:26932697.
  • 26
    Mathur SP: Autoimmunity in endometriosis: relevance to infertility. Am J Reprod Immunol 2000; 44:8995.
  • 27
    Tomassetti C, Meuleman C, Pexsters A, Mihalyi A, Kyama C, Simsa P, D’Hooghe TM: Endometriosis, recurrent miscarriage and implantation failure: is there an immunological link? Reprod Biomed Online 2006; 13:5864.
  • 28
    de Ziegler D, Borghese B, Chapron C: Endometriosis and infertility: pathophysiology and management. Lancet 2010; 376:730738.
  • 29
    Sarapik A, Haller-Kikkatalo K, Utt M, Teesalu K, Salumets A, Uibo R: Serum anti-endometrial antibodies in infertile women – potential risk factor for implantation failure. Am J Reprod Immunol 2010; 63:349357.
  • 30
    Krikun G, Schatz F, Taylor H, Lockwood CJ: Endometriosis and tissue factor. Ann NY Acad Sci 2008; 1127:101105.
  • 31
    Inagaki J, Hao L, Nakatsuka M, Yasuda T, Hiramatsu Y, Shoenfeld Y, Matsuura E: A possible mechanism of autoimmune-mediated infertility in women with endometriosis. Am J Reprod Immunol 2011; doi: 10.1111/j.1600-0897.2010.00956.x.
  • 32
    Kobayashi H, Sumimoto K, Moniwa N, Imai M, Takakura K, Kuromaki T, Morioka E, Arisawa K, Terao T: Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan. Int J Gynecol Cancer 2007; 17:3743.
  • 33
    Melin A, Sparén P, Persson I, Bergqvist A: Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod 2006; 21:12371242.
  • 34
    Mandai M, Yamaguchi K, Matsumura N, Baba T, Konishi I: Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol 2009; 14:383391.
  • 35
    Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, Senz J, McConechy MK, Anglesio MS, Kalloger SE, Yang W, Heravi-Moussavi A, Giuliany R, Chow C, Fee J, Zayed A, Prentice L, Melnyk N, Turashvili G, Delaney AD, Madore J, Yip S, McPherson AW, Ha G, Bell L, Fereday S, Tam A, Galletta L, Tonin PN, Provencher D, Miller D, Jones SJ, Moore RA, Morin GB, Oloumi A, Boyd N, Aparicio SA, Shih IeM, Mes-Masson AM, Bowtell DD, Hirst M, Gilks B, Marra MA, Huntsman DG: ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med 2010; 363:15321543.
  • 36
    Vercellini P, Crosignani P, Somigliana E, Viganò P, Frattaruolo MP, Fedele L: ‘Waiting for Godot’: a commonsense approach to the medical treatment of endometriosis. Hum Reprod 2011; 26:313.
  • 37
    Guo SW: Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? Gynecol Obstet Invest 2007; 63:7197.
  • 38
    Zhang JJ, Xu ZM, Zhang CM, Dai HY, Ji XQ, Wang XF, Li C: Pyrrolidine dithiocarbamate inhibits nuclear factor-κB pathway activation, and regulates adhesion, migration, invasion and apoptosis of endometriotic stromal cells. Mol Hum Reprod 2011; 17:175181.
  • 39
    Lu Y, Sun Q, Zheng Y, Liu X, Geng JG, Guo SW: The role of nuclear factor-kappa-B p50 subunit in the development of endometriosis. Front Biosci (Elite Ed) 2011; 3:591603.
  • 40
    Nothnick WB: Endometriosis: in search of optimal treatment. Minerva Ginecol 2010; 62:1731.
  • 41
    Lv D, Song H, Shi G: Anti-TNF-alpha treatment for pelvic pain associated with endometriosis. Cochrane Database Syst Rev 2010; 3:CD008088.
  • 42
    Krikun G, Hu Z, Osteen K, Bruner-Tran KL, Schatz F, Taylor HS, Toti P, Arcuri F, Konigsberg W, Garen A, Booth CJ, Lockwood CJ: The immunoconjugate “icon” targets aberrantly expressed endothelial tissue factor causing regression of endometriosis. Am J Pathol 2010; 176:10501056.